Murphy & Mullick Capital Management
PJP icon

Murphy & Mullick Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Murphy & Mullick Capital Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.2K Hold
115
– – 0.01% 462
2026
Q2 		$13.6K Hold
115
– – 0.01% 459
2026
Q1 		$11.9K Hold
115
– – 0.01% 453
2025
Q4 		$12K Hold
115
– – 0.01% 459
2025
Q3 		$11K Hold
115
– – 0.01% 458
2025
Q2 		$9.18K Hold
115
– – 0.01% 471
2025
Q1 		$10K Hold
115
– – 0.01% 446
2024
Q4 		$9.5K Buy
+115
New +$9.9K 0.01% 445

Other funds holding PJP

HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Beacon Harbor Wealth Advisors
Beacon Harbor Wealth Advisors Virginia Beach, Virginia $526M AUM 34.64% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Trek Financial
Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vicus Capital
Vicus Capital State College, Pennsylvania $1.58B AUM 16.34% 1-Year Est. Return
Joseph Group Capital Management
Joseph Group Capital Management Columbus, Ohio $562M AUM 15.17% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Trilogy Capital
Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Murphy & Mullick Capital Management's PJP Position: Q3 2026 in Review

Murphy & Mullick Capital Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 115 shares worth $14.2K. The position accounts for 0.01% of the portfolio, ranked #462.

Murphy & Mullick Capital Management first reported a position in PJP in Q4 2024 and has held it in 8 quarters since. 75 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Murphy & Mullick Capital Management held 115 shares of Invesco Pharmaceuticals ETF worth $14.2K as of Q3 2026.
  • Murphy & Mullick Capital Management left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
  • Invesco Pharmaceuticals ETF made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #462 holding.
  • Murphy & Mullick Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2024 and has held it in 8 quarters since.
  • 75 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.